Coppell Advisory Solutions LLC Ascendis Pharma A/S Transaction History
Coppell Advisory Solutions LLC
- $502 Billion
- Q4 2023
A detailed history of Coppell Advisory Solutions LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 141 shares of ASND stock, worth $18,919. This represents 0.0% of its overall portfolio holdings.
Number of Shares
141
Previous 76
85.53%
Holding current value
$18,919
Previous $136,000
9801.47%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ASND
# of Institutions
211Shares Held
46.5MCall Options Held
310KPut Options Held
306K-
Artisan Partners Limited Partnership Milwaukee, WI5.67MShares$761 Million1.32% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.08MShares$547 Million3.29% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.97MShares$532 Million7.23% of portfolio
-
Janus Henderson Group PLC London, X03.77MShares$505 Million0.32% of portfolio
-
Wellington Management Group LLP Boston, MA2.75MShares$368 Million0.08% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.49B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...